LENZ Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
LENZ Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2023.
  • LENZ Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $1.6M, a 745% increase year-over-year.
  • LENZ Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $12.8M, a 78.5% increase year-over-year.
  • LENZ Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $10.6M, a 21.9% decline from 2022.
  • LENZ Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $13.5M, a 71.9% increase from 2021.
  • LENZ Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $7.87M, a 4347% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $10.6M -$2.96M -21.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 $13.5M +$5.66M +71.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 $7.87M +$7.69M +4347% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-20
2020 $177K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.